BioMedGPS, the leading provider of real-time healthcare business intelligence and competitive metrics, announces launch of two new SmartTRAK modules: Total Joints and Wound External Devices. These two markets reached over $6.5B and $1.2B in US revenues, respectively, in 2012, according to BioMedGPS. SmartTRAK Total Joints and Wound External Devices, the newest offerings for SmartTRAK™ Business Intelligence Hub, deliver up-to-date market data and analysis on a versatile digital platform, effectively networking an entire organization with shared insights and real-time information.

“The market for Wound External Devices will see continued growth as the US diabetic population—most vulnerable to chronic wounds–increases. BioMedGPS projects the number of chronic wounds will exceed 3 million in the US by 2016,” states Susan Paquette, SmartTRAK Advanced Wound Care Senior Analyst.

“Hip and knee replacements are expected to see positive growth following two years of stalled procedural volumes. As the US population ages and younger people opt for joint replacement, BioMedGPS expects the US hip and knee replacement markets to reach $3.2B and $4.4B in 2016 respectively,” reports Lisa Mahan, Managing Editor, Orthopedics.

SmartTRAK Total Joints and Wound External Devices offer a powerful combination of real-time information, deep industry content, and analysis from domain experts. SmartTRAK Total Joints profiles 58 public and privately held companies developing or marketing over 585 hip and knee replacement products worldwide, along with 5-year market forecasts. SmartTRAK Wound External Devices covers 38 companies and over 65 products including negative pressure wound therapy, energy and debridement devices and topical oxygen therapy. Unlike static market reports, SmartTRAK is the only source for up-to-date, broadly sourced and validated business information on companies, products and markets, combined with built-in enterprise collaboration tools. Other SmartTRAK Business Intelligence modules include OrthoBio, Spine, Extremities, and Wound Biologics.

Companies looking to expand their market presence, gain understanding of market drivers, and evaluate the global competitive landscape can find the strategic information they need by subscribing to BioMedGPS's SmartTRAK Business Intelligence Hub, the first enterprise-wide hub for business intelligence.

About BioMedGPS, LLC

BioMedGPS, LLC provides online business intelligence and dynamic decision-making tools for life science executives ― transforming the delivery of healthcare business intelligence. BioMedGPS’ founder is Sharon O’Reilly, also the founder of Medtech Insight. To learn more about SmartTRAK, visit http://biomedgps.com/smarttrak.